Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yana Svetlichnaya"'
Autor:
Jacqueline T. DesJardin, Yana Svetlichnaya, Nicholas A. Kolaitis, Steven R. Hays, Jasleen Kukreja, Nelson B. Schiller, Lucas S. Zier, Jonathan P. Singer, Teresa De Marco
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 1, Pp n/a-n/a (2023)
Abstract Noninvasive assessment of pulmonary hemodynamics is often performed by echocardiographic estimation of the pulmonary artery systolic pressure (ePASP), despite limitations in the advanced lung disease population. Other noninvasive hemodynamic
Externí odkaz:
https://doaj.org/article/b12b90c63add41f6a19965d127ea30a5
Autor:
Jacqueline T. DesJardin, Yana Svetlichnaya, Nicholas A. Kolaitis, Steven R. Hays, Jasleen Kukreja, Nelson B. Schiller, Lucas S. Zier, Jonathan P. Singer, Teresa De Marco
Publikováno v:
Pulmonary circulation, vol 13, iss 1
Noninvasive assessment of pulmonary hemodynamics is often performed by echocardiographic estimation of the pulmonary artery systolic pressure (ePASP), despite limitations in the advanced lung disease population. Other noninvasive hemodynamic variable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3e58ecf4dbb476760de2d13534f3bca
https://pubmed.ncbi.nlm.nih.gov/36618711
https://pubmed.ncbi.nlm.nih.gov/36618711
Autor:
Nicholas A. Kolaitis, Mandar A. Aras, Van N. Selby, Alexander Papolos, Francis Y. Yao, Jacqueline T. DesJardin, Teresa De Marco, Yana Svetlichnaya, Lucas S. Zier, John P. Roberts, Liviu Klein, Marcella Manicardi
Publikováno v:
Clinical transplantation. 33(7)
Despite limitations in sensitivity and specificity, estimation of the pulmonary artery systolic pressure (ePASP) on echocardiography is used for portopulmonary hypertension (PoPH) screening in liver transplant (LT) candidates. We proposed that altern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd8552e150352fda50d438e4d873bae
https://pubmed.ncbi.nlm.nih.gov/31074522
https://pubmed.ncbi.nlm.nih.gov/31074522
Publikováno v:
Heart rhythm. 14(4)
Background Antiarrhythmic therapy is commonly used for suppression of arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) in conjunction with implantable cardioverter–defibrillators and catheter ablation. The efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d35535dc818c41927129997dae69dc8
https://pubmed.ncbi.nlm.nih.gov/28089876
https://pubmed.ncbi.nlm.nih.gov/28089876